WallStSmart

Hudbay Minerals Inc. (HBM)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Hudbay Minerals Inc. generates 754% more annual revenue ($2.21B vs $258.90M). HBM leads profitability with a 25.7% profit margin vs -15.5%. HBM earns a higher WallStSmart Score of 75/100 (B).

HBM

Strong Buy

75

out of 100

Grade: B

Growth: 7.3Profit: 8.5Value: 10.0Quality: 5.0
Piotroski: 2/9Altman Z: 1.39

ZEPP

Hold

43

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 5.0Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

HBMUndervalued (+60.8%)

Margin of Safety

+60.8%

Fair Value

$67.39

Current Price

$20.02

$47.37 discount

UndervaluedFair: $67.39Overvalued

Intrinsic value data unavailable for ZEPP.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

HBM5 strengths · Avg: 8.2/10
Profit MarginProfitability
25.7%9/10

Keeps 26 of every $100 in revenue as profit

P/E RatioValuation
13.9x8/10

Attractively priced relative to earnings

Price/BookValuation
2.5x8/10

Reasonable price relative to book value

Operating MarginProfitability
29.8%8/10

Strong operational efficiency at 29.8%

Revenue GrowthGrowth
25.3%8/10

Revenue surging 25.3% year-over-year

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.0x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

HBM3 concerns · Avg: 3.0/10
PEG RatioValuation
2.094/10

Expensive relative to growth rate

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Altman Z-ScoreHealth
1.392/10

Distress zone — elevated risk

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$216.30M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-15.5%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : HBM

The strongest argument for HBM centers on Profit Margin, P/E Ratio, Price/Book. Profitability is solid with margins at 25.7% and operating margin at 29.8%. Revenue growth of 25.3% demonstrates continued momentum.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : HBM

The primary concerns for HBM are PEG Ratio, Piotroski F-Score, Altman Z-Score.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

HBM profiles as a growth stock while ZEPP is a hypergrowth play — different risk/reward profiles.

HBM carries more volatility with a beta of 2.03 — expect wider price swings.

ZEPP is growing revenue faster at 43.0% — sustainability is the question.

Monitor COPPER industry trends, competitive dynamics, and regulatory changes.

Bottom Line

HBM scores higher overall (75/100 vs 43/100), backed by strong 25.7% margins and 25.3% revenue growth. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Hudbay Minerals Inc.

BASIC MATERIALS · COPPER · USA

Hudbay Minerals Inc., a diversified mining company, focuses on the discovery, production and marketing of base and precious metals in North and South America. The company is headquartered in Toronto, Canada.

Visit Website →

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?